Company / Gross Margin
Progyny Gross Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
23.6%
FY2025
5-year range
21.3% / 23.6%
FY2021-FY2025
Trend
+8.8%
vs FY2024
Sector context
#84 of 91
Health Care
What the data says
Among 91 Health Care companies, Progyny is in the bottom 8% for gross margin. Gross Margin has fluctuated over the past 6 years, ranging from 20.3% in FY2020 to 23.6% in FY2025.
Based on SEC 10-K filings.
23.6% in FY2025 with a 5-year CAGR of +3.3%.
Improved from 21.9% to 23.6% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +2.4pp
- 5-Year Change
- +3.3pp
- 10-Year Change
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 91This company 23.6% Sector average 53.8%
▼
-56.1% below sector average
Key checks
Key Insights
- In FY2025, gross margin increased 8.8% year-over-year.
- Currently 30.2pp below the Health Care sector average.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 23.6% | +8.8% |
| FY2024 | 21.7% | -1.0% |
| FY2023 | 21.9% | +3.2% |
| FY2022 | 21.3% | -5.1% |
| FY2021 | 22.4% | +10.3% |
| FY2020 | 20.3% | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026